ArticleOncoTargets and therapy2016

A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials.

Liang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.